PersianMeow,
Thanks for a reply with considerate answers.
I would like to average down, but if so, I'd have to wait for it to go into the teens first.
The FDA really sucks in a variety of ways.
The INNV CEO might want to stop saying that he anticipates fluticare approval in Q2, then Q3 and then Q4, because each Q that it doesn't happen, probably screws over the PPS even more?
It's amazing to me, that before INNV was more so on the radar, that it would go up, double, or triple in a day, based on not much press, but now since the MM (market makers/market manipulators) are aware of INNV, it seems that no amount of good press will boost INNVs price.
The real kicker here will be if when fluticare gets approved, the PPS doesn't go up at all.
The real kicker will be when it takes a couple of years from now, for INNVs price to go up from .25
